Skip to main content
Photo of  Kenneth E. Sherman, MD, PhD

Kenneth E. Sherman, MD, PhD

Professor

Division Chief; Robert and Helen Gould Endowed Professorship

Internal Medicine | College of Medicine

Education/Credentials
  • Bachelor's Degree: Rutgers University
  • Doctoral Degree: Rutgers University
  • Medical Degree: George Washington University
  • Research Fellowship : American Red Cross Blood Research Center
  • Residency: Tripler Army Medical Center
  • Fellowship: Fitzsimons Army Medical Center
Board Certifications & Licenses

American Board of Internal Medicine (Gastroenterology) (Certification Date: 20120215)
American Board of Internal Medicine (Certification Date: 19880915)

Specialties

Gastroenterology
Internal Medicine

Research Interests

Viral Hepatitis - Molecular Heterogeneity, Diagnosis and Treatment, Liver Disease in HIV Infected Patients, Drug Hepatotoxicity.

Contact Information

Clinical Interests

Gastroenterology

Hepatology

Autoimmune Hepatitis

Nonalcoholic Fatty Liver Disease (NAFLD)

Nonalcoholic Steatohepatitis (NASH)

Viral Hepatitis

Peer Reviewed Publications

Baum, Marianna K; Tamargo, Javier A; Ehman, Richard L; Sherman, Kenneth E; Chen, Jun; Liu, Qingyun; Mandler, Raul N; Teeman, Colby; Martinez, Sabrina S; Campa, Adriana 2021. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug and alcohol dependence, 220 , 108531

Jose, Arun; Shah, Shimul A; Anwar, Nadeem; Jones, Courtney R; Sherman, Kenneth E; Elwing, Jean M 2021. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Kong, Ling; Karns, Rebekah; Shata, Mohamed Tarek M; Brown, Jennifer L; Lyons, Michael S; Sherman, Kenneth E; Blackard, Jason T 2021. The synthetic opioid fentanyl enhances viral replication in vitro. PloS one, 16 4, e0249581

Sherman, Kenneth E; Kottilil, Shyam; Rouster, Susan D; Abdel-Hameed, Enass A; Boyce, Ceejay L; Meeds, Heidi L; Terrault, Norah; Shata, M Tarek 2021. Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons. AIDS research and human retroviruses, ,

Sherman, Kenneth E; Meeds, Heidi L; Rouster, Susan D; Abdel-Hameed, Enass A; Hernandez, Jacqueline; Tamargo, Javier; Chen, Jun; Ehman, Richard L; Baum, Marianna 2021. Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis. Open forum infectious diseases, 8 6, ofab203

Sherman, Kenneth E; Rouster, Susan D; Meeds, Heidi; Tamargo, Javier; Chen, Jun; Ehman, Richard; Baum, Marianna 2021. PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV. Biology, 10 3,

Tamargo, Javier A; Hernandez-Boyer, Jacqueline; Teeman, Colby; Martin, Haley R; Huang, Yongjun; Johnson, Angelique; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Rouster, Susan D; Meeds, Heidi L; Sherman, Kenneth E; Baum, Marianna K 2021. Immune activation: A link between food insecurity and chronic disease in people living with HIV. The Journal of infectious diseases, ,

Tamargo, Javier A; Meade, Christina S; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Sherman, Kenneth E; Baum, Marianna K 2021. Food Insecurity and Cognitive Impairment in the Miami Adult Studies on HIV (MASH) Cohort. The Journal of nutrition, 151 4, 979-986

Tamargo, Javier A; Sherman, Kenneth E; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Hernandez, Jacqueline; Teeman, Colby; Mandler, Raul N; Chen, Jun; Ehman, Richard L; Baum, Marianna K 2021. Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV. The American journal of clinical nutrition, 113 3, 593-601

Abdel-Hameed, Enass A; Rouster, Susan D; Kottilil, Shyam; Sherman, Kenneth E 2020. The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Bari, Khurram; Shah, Shimul A; Kaiser, Tiffany E; Cohen, Robert M; Anwar, Nadeem; Kleesattel, David; Sherman, Kenneth E 2020. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a trial. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Butt, Adeel A; Yan, Peng; Aslam, Samia; Abou-Samra, Abdul-Badi; Sherman, Kenneth E; Shaikh, Obaid S 2020. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 3, 664-666

Butt, Adeel A; Yan, Peng; Aslam, Samia; Sherman, Kenneth E; Siraj, Dawd; Safdar, Nasia; Hameed, Bilal 2020. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 92 , 184-188

Butt, Adeel Ajwad; Yan, Peng; Shaikh, Obaid S; Lo Re, Vincent; Abou-Samra, Abdul-Badi; Sherman, Kenneth E 2020. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study. Journal of hepatology, 73 2, 277-284

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Alloway, Rita R; Sherman, Kenneth E 2020. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 75 6, 857-867

Gentene, Anthony J; Bell, Allison M; Pence, Alicia; Thomas, Kelly; Jakubecz, Collin; Stacy, Elizabeth; Woolf, Brittany; Guido, Maria Rose; Mueller, Eric W; Sherman, Kenneth E 2020. Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals. The Annals of pharmacotherapy, , 1060028020964117

Seth, Aradhna; Sherman, Kenneth E 2020. Editorial: HCV Cure is the Start of the End For Those With Advanced Fibrosis/Cirrhosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Seth, Aradhna; Sherman, Kenneth E 2020. Hepatitis E: What We Think We Know. Clinical liver disease, 15 Suppl 1, S37-S44

Sherman, Kenneth E; Abdel-Hameed, Enass A; Ehman, Richard L; Rouster, Susan D; Campa, Adriana; Martinez, Sabrina Sales; Huang, Yongjun; Zarini, Gustavo G; Hernandez, Jacqueline; Teeman, Colby; Tamargo, Javier; Liu, Qingyun; Mandler, Raul; Baum, Marianna K 2020. Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index. Digestive diseases and sciences, 65 4, 1252-1257

Sise, Meghan E; Goldberg, David S; Kort, Jens J; Schaubel, Douglas E; Alloway, Rita R; Durand, Christine M; Fontana, Robert J; Brown, Robert S; Friedewald, John J; Prenner, Stacey; Landis, J Richard; Fernando, Melissa; Phillips, Caitlin C; Woodle, E Steve; Rike-Shields, Adele; Sherman, Kenneth E; Elias, Nahel; Williams, Winfred W; Gustafson, Jenna L; Desai, Niraj M; Barnaba, Brittany; Norman, Silas P; Doshi, Mona; Sultan, Samuel T; Aull, Meredith J; Levitsky, Josh; Belshe, Dianne S; Chung, Raymond T; Reese, Peter P 2020. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. Journal of the American Society of Nephrology : JASN, ,

Zarini, Gustavo; Sales Martinez, Sabrina; Campa, Adriana; Sherman, Kenneth; Tamargo, Javier; Hernandez Boyer, Jacqueline; Teeman, Colby; Johnson, Angelique; Degarege, Abraham; Greer, Pedro; Liu, Qingyun; Huang, Yongjun; Mandler, Raul; Choi, David; Baum, Marianna K 2020. Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort. Journal of women's health (2002), ,

Blackard, Jason T; Kong, Ling; Rouster, Susan D; Karns, Rebekah; Horn, Paul S; Kottilil, Shyam; Shata, M Tarek; Sherman, Kenneth E 2019. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. PloS one, 14 10, e0224523

Blackard, Jason T; Kwara, Awewura; Sherman, Kenneth E 2019. In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of hepatology, 71 6, 1259-1260

Dao, Ann; Cuffy, Madison; Kaiser, Tiffany E; Loethen, Ashley; Cafardi, John; Luckett, Keith; Rike, Adele Helen; Cardi, Michael; Alloway, Rita R; Govil, Amit; Diwan, Tayyab; Sherman, Kenneth E; Shah, Shimul A; Woodle, Ervin Steve 2019. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical transplantation, 33 7, e13598

Eckman, Mark H; Ward, John W; Sherman, Kenneth E 2019. Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17 5, 930-939.e9

Farooq, Priya D; Sherman, Kenneth E 2019. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV. Current HIV/AIDS reports, 16 5, 395-403

Foster, Graham R; Dore, Gregory J; Wang, Stanley; Grebely, Jason; Sherman, Kenneth E; Baumgarten, Axel; Conway, Brian; Jackson, Daniel; Asselah, Tarik; Gschwantler, Michael; Tomasiewicz, Krzysztof; Aguilar, Humberto; Asatryan, Armen; Hu, Yiran; Mensa, Federico J 2019. Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies. Drug and alcohol dependence, 194 , 487-494

Hu, Ke-Qin; Cui, Wei; Rouster, Susan D; Sherman, Kenneth E 2019. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals. World journal of hepatology, 11 5, 442-449

Narayanan, Shivakumar; Abutaleb, Ameer; Sherman, Kenneth E; Kottilil, Shyam 2019. Clinical features and determinants of chronicity in hepatitis E virus infection. Journal of viral hepatitis, 26 4, 414-421

Seth, Aradhna; Sherman, Kenneth E 2019. Fatty liver disease in persons with HIV infection. Topics in antiviral medicine, 27 2, 75-82

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Rouster, Susan D; Yu, Li; Liang, Meina; Song, Esther; Esser, Mark T; Shire, Norah; Sherman, Kenneth E 2019. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathogens & immunity, 4 1, 39-65

Sherman, Kenneth E; Abdel-Hameed, Enass; Rouster, Susan D; Shata, Mohamed Tarek M; Blackard, Jason T; Safaie, Parham; Kroner, Barbara; Preiss, Liliana; Horn, Paul S; Kottilil, Shyam 2019. Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 11, 1911-1918

Sherman, Kenneth E; Peters, Marion G; Thomas, David L 2019. HIV and the liver. Topics in antiviral medicine, 27 3, 101-110

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Aliota, Matthew T; Blackard, Jason T; Dean, Gary E 2019. Zika virus replication and cytopathic effects in liver cells. PloS one, 14 3, e0214016

Abdel-Hameed, Enass A; Rouster, Susan D; Boyce, Ceejay L; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Sherman, Kenneth E 2018. Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients. Digestive diseases and sciences, 63 3, 645-652

Abutaleb, Ameer; Sherman, Kenneth E 2018. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatology international, 12 6, 500-509

Anwar, Nadeem; Sherman, Kenneth E 2018. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical? Journal of viral hepatitis, 25 10, 1110-1115

Bari, Khurram; Luckett, Keith; Kaiser, Tiffany; Diwan, Tayyab; Cuffy, Madison; Schoech, Michael R; Safdar, Kamran; Blackard, Jason T; Apewokin, Senu; Paterno, Flavio; Sherman, Kenneth E; Zucker, Stephen D; Anwar, Nadeem; Shah, Shimul A 2018. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients. Hepatology (Baltimore, Md.), 67 5, 1673-1682

Blackard, Jason T; Sherman, Kenneth E 2018. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Reviews in medical virology, 28 4, e1984

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients. Annals of internal medicine, 169 12, 898-899

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis. Annals of internal medicine, 169 4, 214-223

Rockstroh, Jürgen K; Lacombe, Karine; Viani, Rolando M; Orkin, Chloe; Wyles, David; Luetkemeyer, Anne F; Soto-Malave, Ruth; Flisiak, Robert; Bhagani, Sanjay; Sherman, Kenneth E; Shimonova, Tatiana; Ruane, Peter; Sasadeusz, Joseph; Slim, Jihad; Zhang, Zhenzhen; Samanta, Suvajit; Ng, Teresa I; Gulati, Abhishek; Kosloski, Matthew P; Shulman, Nancy S; Trinh, Roger; Sulkowski, Mark 2018. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67 7, 1010-1017

Safaie, Parham; Razeghi, Sanam; Rouster, Susan D; Privitera, Isaac; Sherman, Kenneth E 2018. Hepatitis D diagnostics:Utilization and testing in the United States. Virus research, 250 , 114-117

Sherman, Kenneth E; Rouster, Susan D; Kang, Minhee; Umbleja, Triin; Sterling, Richard; Butt, Adeel A 2018. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive diseases and sciences, 63 11, 2969-2974

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Shata, Tarek M; Archampong, Timothy; Kwara, Awewura; Aliota, Matthew T; Blackard, Jason T 2018. Zika Virus Exposure in an HIV-Infected Cohort in Ghana. Journal of acquired immune deficiency syndromes (1999), 78 5, e35-e38

Sherman, Kenneth E; Shah, Vijay H 2018. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia. Gastroenterology, 154 3, 453-456

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D 2018. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine, 36 4, 453-460

Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D; Liu, Lin; Li, Eric; Zhao, Lisa; Lim, Joseph K; Morelli, Giuseppe; Kuo, Alexander; Levitsky, Josh; Sherman, Kenneth E; Frazier, Lynn M; Ramani, Ananthakrishnan; Peter, Joy; Akuskevich, Lucy; Fried, Michael W; Nelson, David R 2018. Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Scientific reports, 8 1, 3199

Abdel-Hameed, Enass A; Rouster, Susan D; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Goodman, Zachary D; Sherman, Kenneth E 2017. Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis. Journal of acquired immune deficiency syndromes (1999), 74 3, 353-358

Butt, A A; Ren, Y; Marks, K; Shaikh, O S; Sherman, K E 2017. Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES. Alimentary pharmacology & therapeutics, 45 1, 150-159

Judge, Chelsey J; Kostadinova, Lenche; Sherman, Kenneth E; Butt, Adeel A; Falck-Ytter, Yngve; Funderburg, Nicholas T; Landay, Alan L; Lederman, Michael M; Sieg, Scott F; Sandberg, Johan K; Anthony, Donald D 2017. CD56bright NK IL-7R? expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. Journal of leukocyte biology, 102 1, 171-184

Kiser, Jennifer J; Lu, Darlene; Rosenkranz, Susan L; Morse, Gene D; DiFrancesco, Robin; Sherman, Kenneth E; Butt, Adeel A 2017. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s. Drugs in R&D, 17 4, 557-567

Murrison, Liza Bronner; Sherman, Kenneth E 2017. The Enigma of Hepatitis E Virus. Gastroenterology & hepatology, 13 8, 484-491

Ragni, Margaret V; Humar, Abhinav; Stock, Peter G; Blumberg, Emily A; Eghtesad, Bijan; Fung, John J; Stosor, Valentina; Nissen, Nicholas; Wong, Michael T; Sherman, Kenneth E; Stablein, Donald M; Barin, Burc 2017. Hemophilia Liver Transplantation Observational Study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 23 6, 762-768

Sherman, Kenneth E; Kang, Minhee; Sterling, Richard; Umbleja, Triin; Marks, Kristen; Kiser, Jennifer J; Alston-Smith, Beverly; Greaves, Wayne; Butt, Adeel A; The Actg Birth Study Team, 2017. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World journal of hepatology, 9 4, 217-223

Sherman, Kenneth E; Peters, Marion G; Thomas, David 2017. Human immunodeficiency virus and liver disease: A comprehensive update. Hepatology communications, 1 10, 987-1001

Soriano, Vincent; Sherman, Kenneth E; Barreiro, Pablo 2017. Hepatitis delta and HIV infection. AIDS (London, England), 31 7, 875-884

Abdel-Hameed, Enass A; Rouster, Susan D; Ji, Hong; Ulm, Ashley; Hetta, Helal F; Anwar, Nadeem; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy. Viral immunology, 29 4, 252-8

Blackard, Jason T; Ma, Gang; Polen, Clarissa; DuBois, Juwen C; Gast, Jonathon; Radens, Caleb M; Sterling, Richard K; Sherman, Kenneth E 2016. Recombination among GB virus C (GBV-C) isolates in the United States. The Journal of general virology, 97 7, 1537-1544

Butt, A A; Yan, P; Marks, K; Shaikh, O S; Sherman, K E 2016. Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES. Alimentary pharmacology & therapeutics, 44 7, 728-37

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 9, 1275-83

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 5, 651-8

Campa, Adriana; Martinez, Sabrina Sales; Sherman, Kenneth E; Greer, Joe Pedro; Li, Yinghui; Garcia, Stephanie; Stewart, Tiffanie; Ibrahimou, Boubakari; Williams, O Dale; Baum, Marianna K 2016. Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort. Journal of drug abuse, 2 4,

Feld, Jordan J; Maan, Raoel; Zeuzem, Stefan; Kuo, Alexander; Nelson, David R; Di Bisceglie, Adrian M; Manns, Michael P; Sherman, Ken; Frazier, Lynn M; Sterling, Richard; Mailliard, Mark; Schmidt, Monica; Akushevich, Lucy; Vainorius, Monika; Fried, Michael W 2016. Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63 6, 776-783

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Medhat, Ahmed; Nassar, Mahmoud I; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. Journal of medical microbiology, 65 8, 703-712

Judge, Chelsey J; Sandberg, Johan K; Funderburg, Nicholas T; Sherman, Kenneth E; Butt, Adeel A; Kang, Minhee; Landay, Alan L; Lederman, Michael M; Anthony, Donald D 2016. Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of acquired immune deficiency syndromes (1999), 73 3, 258-262

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E 2016. Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 9, 1066-71

Mehta, Minesh; Hetta, Helal F; Abdel-Hameed, Enass A; Rouster, Susan D; Hossain, MdMonir; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; El-Mokhtar, Mohamed A; Abdelwahab, Sayed F; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. Archives of virology, 161 11, 3161-9

Reau, Nancy; Fried, Michael W; Nelson, David R; Brown, Robert S; Everson, Gregory T; Gordon, Stuart C; Jacobson, Ira M; Lim, Joseph K; Pockros, Paul J; Reddy, K Rajender; Sherman, Kenneth E 2016. HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver international : official journal of the International Association for the Study of the Liver, 36 4, 488-502

Sherman, K E; Ke, R; Rouster, S D; Abdel-Hameed, E A; Park, C; Palascak, J; Perelson, A S 2016. Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 22 4, 543-8

Butt, A A; Yan, P; Shaikh, O S; Freiberg, M S; Lo Re, V; Justice, A C; Sherman, K E 2015. Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings. Journal of viral hepatitis, 22 9, 691-700

Butt, Adeel A; Yan, Peng; Lo Re, Vincent; Rimland, David; Goetz, Matthew B; Leaf, David; Freiberg, Matthew S; Klein, Marina B; Justice, Amy C; Sherman, Kenneth E 2015. Liver fibrosis progression in hepatitis C virus infection after seroconversion. JAMA internal medicine, 175 2, 178-85

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Nassar, Mahmoud I; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2015. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. Journal of gastroenterology and hepatology, 30 10, 1543-51

Jensen, Donald; Sherman, Kenneth E; Hézode, Christophe; Pol, Stanislas; Zeuzem, Stefan; de Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong; Bernstein, David; McPhee, Fiona; Hennicken, Delphine; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie 2015. Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders. Journal of hepatology, 63 1, 30-7

Sherman, Kenneth E; Rockstroh, Juergen; Thomas, David 2015. Human immunodeficiency virus and liver disease: An update. Hepatology (Baltimore, Md.), 62 6, 1871-82

Shire, Norah J; Sherman, Kenneth E 2015. Epidemiology of Hepatitis C Virus: A Battle on New Frontiers. Gastroenterology clinics of North America, 44 4, 699-716

Wyles, David L; Ruane, Peter J; Sulkowski, Mark S; Dieterich, Douglas; Luetkemeyer, Anne; Morgan, Timothy R; Sherman, Kenneth E; Dretler, Robin; Fishbein, Dawn; Gathe, Joseph C; Henn, Sarah; Hinestrosa, Federico; Huynh, Charles; McDonald, Cheryl; Mills, Anthony; Overton, Edgar Turner; Ramgopal, Moti; Rashbaum, Bruce; Ray, Graham; Scarsella, Anthony; Yozviak, Joseph; McPhee, Fiona; Liu, Zhaohui; Hughes, Eric; Yin, Philip D; Noviello, Stephanie; Ackerman, Peter 2015. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. The New England journal of medicine, 373 8, 714-25

Abdel-Hameed, Enass A; Ji, Hong; Sherman, Kenneth E; Shata, Mohamed T M 2014. Epigenetic modification of FOXP3 in patients with chronic HIV infection. Journal of acquired immune deficiency syndromes (1999), 65 1, 19-26

Anwar, Nadeem; Sherman, Kenneth E 2014. HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure. Clinical liver disease, 4 4, 80-83

Blackard, Jason T; Ma, Gang; Sengupta, Satarupa; Martin, Christina M; Powell, Eleanor A; Shata, M Tarek; Sherman, Kenneth E 2014. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. Journal of medical virology, 86 8, 1332-41

Lin, M V; Charlton, A N; Rouster, S D; Zamor, P J; Sherman, K E 2014. Hepatitis C virus NS3 mutations in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 20 5, 659-65

Schmidt, Warren N; Nelson, David R; Pawlotsky, Jean-Michel; Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2014. Direct-acting antiviral agents and the path to interferon independence. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 12 5, 728-37

Sherman, K E; Terrault, N; Barin, B; Rouster, S D; Shata, M T 2014. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. Journal of viral hepatitis, 21 8, e74-7

Sherman, Kenneth E; Guedj, Jeremie; Shata, Mohamed Tarek; Blackard, Jason T; Rouster, Susan D; Castro, Mario; Feinberg, Judith; Sterling, Richard K; Goodman, Zachary; Aronow, Bruce J; Perelson, Alan S 2014. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science translational medicine, 6 246, 246ra98

Sherman, Kenneth E; Thomas, David; Chung, Raymond T 2014. Human immunodeficiency virus and liver disease forum 2012. Hepatology (Baltimore, Md.), 59 1, 307-17

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Hetta, Helal F; Sherman, Kenneth E 2013. Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). Journal of clinical pathology, 66 11, 967-75

Blackard, Jason T; Ma, Gang; Welge, Jeffrey A; Martin, Christina M; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J 2012. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. Journal of medical virology, 84 2, 242-52

Jennings, Carrie L; Sherman, Kenneth E 2012. Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Current HIV/AIDS reports, 9 3, 231-7

Kemmer, N; Hua, L; Andersen, J W; Chung, R T; Butt, A A; Sherman, K E 2012. Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. Journal of viral hepatitis, 19 11, 792-800

Kong, Ling; Cardona Maya, Walter; Moreno-Fernandez, Maria E; Ma, Gang; Shata, Mohamed T; Sherman, Kenneth E; Chougnet, Claire; Blackard, Jason T 2012. Low-level HIV infection of hepatocytes. Virology journal, 9 , 157

Martin, C M; Welge, J A; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2012. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. Journal of viral hepatitis, 19 10, 716-23

Shata, Mohamed T; Daef, Enas A; Zaki, Maysaa E; Abdelwahab, Sayed F; Marzuuk, Naglaa M; Sobhy, Maha; Rafaat, Marwa; Abdelbaki, Liala; Nafeh, Mohamed A; Hashem, Mohamed; El-Kamary, Samer S; Shardell, Michelle D; Mikhail, Nabiel N; Strickland, George T; Sherman, Kenneth E 2012. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106 10, 613-8

Sherman, Kenneth E 2012. Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 9, 1236-41

Blackard, Jason T; Ma, Gang; Martin, Christina M; Rouster, Susan D; Shata, M Tarek; Sherman, Kenneth E 2011. HIV Variability in the Liver and Evidence of Possible Compartmentalization. AIDS research and human retroviruses, ,

Blackard, Jason T; Welge, Jeffrey A; Taylor, Lynn E; Mayer, Kenneth H; Klein, Robert S; Celentano, David D; Jamieson, Denise J; Gardner, Lytt; Sherman, Kenneth E 2011. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 5, 674-80

Eckman, Mark H; Kaiser, Tiffany E; Sherman, Kenneth E 2011. The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 11, 1294-306

Hernandez, Maria D; Sherman, Kenneth E 2011. HIV/hepatitis C coinfection natural history and disease progression. Current opinion in HIV and AIDS, 6 6, 478-82

Kemmer, Nyingi M; Sherman, Kenneth E 2011. Liver transplantation trends in the HIV population. Digestive diseases and sciences, 56 11, 3393-8

Sherman, Kenneth E 2011. Hepatitis e virus infection: more common than previously realized? Gastroenterology & hepatology, 7 11, 759-61

Sherman, Kenneth E; Flamm, Steven L; Afdhal, Nezam H; Nelson, David R; Sulkowski, Mark S; Everson, Gregory T; Fried, Michael W; Adler, Michael; Reesink, Hendrik W; Martin, Marie; Sankoh, Abdul J; Adda, Nathalie; Kauffman, Robert S; George, Shelley; Wright, Christopher I; Poordad, Fred 2011. Response-guided telaprevir combination treatment for hepatitis C virus infection. The New England journal of medicine, 365 11, 1014-24

Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2011. Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology (Baltimore, Md.), 54 6, 2245-53

Taylor, Lynn E; Holubar, Marisa; Wu, Kunling; Bosch, Ronald J; Wyles, David L; Davis, John A; Mayer, Kenneth H; Sherman, Kenneth E; Tashima, Karen T 2011. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 6, 812-8

Blackard, Jason T; Ma, Gang; Limketkai, Berkeley N; Welge, Jeffrey A; Dryer, Peter D; Martin, Christina M; Hiasa, Yoichi; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Sherman, Kenneth E 2010. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. Journal of clinical microbiology, 48 11, 4256-9

Kemmer, Nyingi M; Sherman, Kenneth E 2010. Hepatitis C-related arthropathy: Diagnostic and treatment considerations. The Journal of musculoskeletal medicine, 27 9, 351-354

Martin, C M; Welge, J A; Shire, N J; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2010. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Journal of viral hepatitis, 17 8, 588-97

McHutchison, John; Goodman, Zachary; Patel, Keyur; Makhlouf, Hala; Rodriguez-Torres, Maribel; Shiffman, Mitchell; Rockey, Don; Husa, Petr; Chuang, Wan-Long; Levine, Robert; Jonas, Mark; Theodore, Dickens; Brigandi, Richard; Webster, Alison; Schultz, Margaret; Watson, Helen; Stancil, Britt; Gardner, Stephen 2010. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology, 138 4, 1365-73, 1373.e1-2

Rashkin, S; Rouster, S; Goodman, Z D; Sherman, K E 2010. T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients. Journal of viral hepatitis, 17 3, 222-6

Schmeltzer, Paul; Sherman, Kenneth E 2010. Occult hepatitis B: clinical implications and treatment decisions. Digestive diseases and sciences, 55 12, 3328-35

Sherman, Kenneth E 2010. Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences, 1194 , 136-40

Sherman, Kenneth E; Andersen, Janet W; Butt, Adeel A; Umbleja, Triin; Alston, Beverly; Koziel, Margaret J; Peters, Marion G; Sulkowski, Mark; Goodman, Zachary D; Chung, Raymond T 2010. Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). Journal of acquired immune deficiency syndromes (1999), ,

Sherman, Kenneth E; Rouster, Susan D; Stanford, Sandra; Blackard, Jason T; Shire, Norah; Koziel, Margaret; Peters, Marion; Chung, Raymond T 2010. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. The Journal of infectious diseases, 201 5, 712-9

Sherman, Kenneth E; Soriano, Vincent; Chung, Raymond T 2010. Human immunodeficiency virus and liver disease: conference proceedings. Hepatology (Baltimore, Md.), 51 3, 1046-54

Sulkowski, Mark S; Shiffman, Mitchell L; Afdhal, Nezam H; Reddy, K Rajender; McCone, Jonathan; Lee, William M; Herrine, Steven K; Harrison, Stephen A; Poordad, F Fred; Koury, Kenneth; Deng, Weiping; Noviello, Stephanie; Pedicone, Lisa D; Brass, Clifford A; Albrecht, Janice K; McHutchison, John G 2010. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology, 139 5, 1602-11, 1611.e1

Atiq, Muslim; Shire, Norah J; Barrett, Anna; Rouster, Susan D; Sherman, Kenneth E; Shata, Mohamed T 2009. Hepatitis E virus antibodies in patients with chronic liver disease. Emerging infectious diseases, 15 3, 479-81

Blackard, Jason T; Rouster, Susan D; Nady, Soad; Galal, Gehan; Marzuuk, Naglaa; Rafaat, Marwaa M; Daef, Enas; El Din, Salwa Seif; Purcell, Robert H; Emerson, Suzanne U; Sherman, Kenneth E; Shata, M Tarek 2009. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 46 2, 140-4

Dryer, Peter D; Limketkai, Berkeley N; Martin, Christina M; Ma, Gang; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Blackard, Jason T 2009. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. The Journal of antimicrobial chemotherapy, 64 5, 945-8

Gordon, Stuart C; Sherman, Kenneth E 2009. Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology, 136 2, 393-6

Martin, Christina M; Welge, Jeffrey A; Shire, Norah J; Shata, Mohamed T; Sherman, Kenneth E; Blackard, Jason T 2009. Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine, 47 3, 194-8

Poynard, Thierry; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Bedossa, Pierre; Mukhopadhyay, Pabak; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice 2009. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology, 136 5, 1618-28.e2

Sherman, Kenneth; Belkin, Igor M; Friedland, Kevin D; O'Reilly, John; Hyde, Kimberly 2009. Accelerated warming and emergent trends in fisheries biomass yields of the world's large marine ecosystems. Ambio, 38 4, 215-24

Shire, Norah J; Rao, Marepalli B; Succop, Paul; Buncher, C Ralph; Andersen, Janet A; Butt, Adeel A; Chung, Raymond T; Sherman, Kenneth E 2009. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 4, 471-80, 480.e1-2

Blackard, J T; Sherman, K E 2008. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? Journal of viral hepatitis, 15 5, 323-30

Blackard, Jason T; Shata, M Tarek; Shire, Norah J; Sherman, Kenneth E 2008. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, Md.), 47 1, 321-31

Dichiara, A J; Atkinson, M; Goodman, Z; Sherman, K E 2008. Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva gastroenterologica e dietologica, 54 3, 307-15

Kemmer, Nyingi; Sherman, Kenneth E 2008. What is the impact of HIV infection on survival after liver transplantation? Nature clinical practice. Gastroenterology & hepatology, 5 8, 426-7

Alatrakchi, Nadia; Graham, Camilla S; van der Vliet, Hans J J; Sherman, Kenneth E; Exley, Mark A; Koziel, Margaret James 2007. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. Journal of virology, 81 11, 5882-92

Blackard, Jason T; Kang, Minhee; St Clair, J Benjamin; Lin, Wenyu; Kamegaya, Yoshitaka; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Andersen, Janet; Chung, Raymond T 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 27 4, 263-9

Blackard, Jason T; Sherman, Kenneth E 2007. Hepatitis C virus coinfection and superinfection. The Journal of infectious diseases, 195 4, 519-24

Shata, M T; Barrett, A; Shire, N J; Abdelwahab, S F; Sobhy, M; Daef, E; El-Kamary, S S; Hashem, M; Engle, R E; Purcell, R H; Emerson, S U; Strickland, G T; Sherman, K E 2007. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. Journal of immunological methods, 328 1-2, 152-61

Sherman, Kenneth E 2007. New paradigms in the management of hepatitis C virus co-infections. Nature clinical practice. Gastroenterology & hepatology, 4 Suppl 1 , S10-6

Sherman, Kenneth E; Fleischer, Russell; Laessig, Katherine; Murray, Jeffrey; Tauber, William; Birnkrant, Debra 2007. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations. Hepatology (Baltimore, Md.), 46 6, 2014-20

Sherman, Kenneth E; Goodman, Zachary D; Sullivan, Sara T; Faris-Young, Sima 2007. Liver biopsy in cirrhotic patients. The American journal of gastroenterology, 102 4, 789-93

Sherman, Kenneth E; Peters, Marion; Koziel, Margaret James 2007. HIV and liver disease forum: conference proceedings. Hepatology (Baltimore, Md.), 45 6, 1566-77

Shire, N J; Welge, J A; Sherman, K E 2007. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis. Journal of viral hepatitis, 14 4, 239-48

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E 2007. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 44 3, 309-14

Atiq, Muslim; Neff, Guy W; Buell, Joseph; Kemmer, Nyingi; Rudich, Steven; Weber, Fred; Sherman, Kenneth 2006. Rhabdomylysis transference during liver transplantation. Transplantation, 81 9, 1359-60

Blackard, Jason T; Kang, Minhee; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Chung, Raymond T 2006. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 26 11, 834-8

Blackard, Jason T; Kemmer, Nyingi; Sherman, Kenneth E 2006. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (Baltimore, Md.), 44 1, 15-22

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2006. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS (London, England), 20 3, 345-51

Mandac, Jamie C; Chaudhry, Sonal; Sherman, Kenneth E; Tomer, Yaron 2006. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore, Md.), 43 4, 661-72

Mann, Elizabeth A; Stanford, Sandra; Sherman, Kenneth E 2006. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus research, 121 1, 51-7

Mrus, Joseph M; Sherman, Kenneth E; Leonard, Anthony C; Sherman, Susan N; Mandell, Karen L; Tsevat, Joel 2006. Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Medical care, 44 2, 158-66

Neff, Guy W; Jayaweera, Dushyantha; Sherman, Kenneth E 2006. Drug-Induced Liver Injury in HIV Patients. Gastroenterology & hepatology, 2 6, 430-437

Peters, Marion G; Andersen, Janet; Lynch, Patrick; Liu, Tun; Alston-Smith, Beverly; Brosgart, Carol L; Jacobson, Jeffrey M; Johnson, Victoria A; Pollard, Richard B; Rooney, James F; Sherman, Kenneth E; Swindells, Susan; Polsky, Bruce 2006. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (Baltimore, Md.), 44 5, 1110-6

Schwarze-Zander, Carolynne; Blackard, Jason T; Zheng, Hui; Addo, Marylyn M; Lin, Wenyu; Robbins, Gregory K; Sherman, Kenneth E; Zdunek, Dietmar; Hess, Georg; Chung, Raymond T 2006. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. The Journal of infectious diseases, 194 4, 410-9

Shire, N J; Sherman, K E 2006. Management of hepatitis B virus in HIV-positive patients. Minerva gastroenterologica e dietologica, 52 1, 67-87

Shire, Norah J; Horn, Paul S; Rouster, Susan D; Stanford, Sandra; Eyster, M Elaine; Sherman, Kenneth E 2006. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology (Baltimore, Md.), 44 5, 1146-57

Shire, Norah J; Welge, Jeffrey A; Sherman, Kenneth E 2006. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine, 24 3, 272-9

Alatrakchi, Nadia; Graham, Camilla S; He, Qi; Sherman, Kenneth E; Koziel, Margaret James 2005. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. The Journal of infectious diseases, 191 5, 702-9

Chun, Sooyun; Sherman, Kenneth E 2005. Treatment of hepatitis C virus/HIV coinfection. Clinics in liver disease, 9 3, 525-33, ix

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E 2005. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. The Journal of infectious diseases, 191 5, 686-93

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2005. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (London, England), 19 8, 767-73

Lienesch, Douglas; Morris, Robert; Metzger, Allan; Debuys, Paige; Sherman, Kenneth 2005. Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. The Journal of rheumatology, 32 3, 489-93

Qin, Hongxing; Shire, Norah J; Keenan, Erica D; Rouster, Susan D; Eyster, M Elaine; Goedert, James J; Koziel, Margaret James; Sherman, Kenneth E 2005. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood, 105 2, 533-41

Sherman, Kenneth E 2005. Treatment of hepatitis C virus and human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 10 Suppl 2, S118-21

Sherman, Kenneth E; Shire, Norah J; Cernohous, Paul; Rouster, Susan D; Omachi, Janice H; Brun, Scott; Da Silva, Barbara 2005. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 8, 1186-95

Sherman, Kenneth E; Shire, Norah J; Rouster, Susan D; Peters, Marion G; James Koziel, Margaret; Chung, Raymond T; Horn, Paul S 2005. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology, 128 2, 313-27

Shire, Norah J; Sherman, Kenneth E 2005. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 Suppl 1 , S63-8

Shire, Norah J; Sherman, Kenneth E 2005. Management of HBV/HIV-coinfected Patients. Seminars in liver disease, 25 Suppl 1 , 48-57

Blackard, Jason T; Yang, Yijun; Bordoni, Paola; Sherman, Kenneth E; Chung, Raymond T 2004. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. The Journal of infectious diseases, 189 8, 1472-81

Chung, Raymond T; Andersen, Janet; Volberding, Paul; Robbins, Gregory K; Liu, Tun; Sherman, Kenneth E; Peters, Marion G; Koziel, Margaret J; Bhan, Atul K; Alston, Beverly; Colquhoun, Dodi; Nevin, Tom; Harb, George; van der Horst, Charles 2004. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. The New England journal of medicine, 351 5, 451-9

Fleischer, Russell; Boxwell, Debra; Sherman, Kenneth E 2004. Nucleoside analogues and mitochondrial toxicity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38 8, e79-80

Graham, Camilla S; Curry, Michael; He, Qi; Afdhal, Nezam; Nunes, David; Fleming, Catherine; Horsburgh, Robert; Craven, Donald; Sherman, Kenneth E; Koziel, Margaret James 2004. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (Baltimore, Md.), 40 1, 125-32

Keenan, Erica D; Rouster, Susan D; Shire, Norah J; Horn, Paul S; Sherman, Kenneth E 2004. Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. The Journal of infectious diseases, 190 3, 511-4

Morelli, Michael S; Rouster, Susan D; Giannella, Ralph A; Sherman, Kenneth E 2004. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2 8, 669-74

Neff, G W; Sherman, K E; Eghtesad, B; Fung, J 2004. Review article: current status of liver transplantation in HIV-infected patients. Alimentary pharmacology & therapeutics, 20 10, 993-1000

Sherman, Kenneth E 2004. HCV and HIV: a tale of two viruses. Reviews in gastroenterological disorders, 4 Suppl 1 , S48-54

Sherman, Kenneth E; Sherman, Susan N; Chenier, Thomas; Tsevat, Joel 2004. Health values of patients with chronic hepatitis C infection. Archives of internal medicine, 164 21, 2377-82

Shire, Norah J; Rouster, Susan D; Rajicic, Natasa; Sherman, Kenneth E 2004. Occult hepatitis B in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 36 3, 869-75

Zucker, Stephen D; Horn, Paul S; Sherman, Kenneth E 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (Baltimore, Md.), 40 4, 827-35

Zucker, Stephen D; Sherman, Kenneth E 2004. Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology, 126 5, 1487-8

Keiserman, Daniela R; Both, Cristiane T; Mattos, Angelo A; Remiao, Jose; Alexandre, Claudio O P; Sherman, Kenneth E 2003. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. The American journal of gastroenterology, 98 4, 878-83

Sherman, Kenneth E 2003. Implications of peginterferon use in special populations infected with HCV. Seminars in liver disease, 23 Suppl 1 , 47-52

Shiramizu, Bruce; Theodore, Dickens; Bassett, Roland; Coel, Marc; Sherman, Kenneth E; Glesby, Marshall J; Chow, Dominic; Alston, Beverly; Colquhoun, Dodi; Merigan, Thomas C; Reichman, Richard C; Berggren, Ruth; Burning, Wendy Jo; Brobst, Susan 2003. Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. Journal of acquired immune deficiency syndromes (1999), 33 3, 329-35

Ajayi, Thomas; Sherman, Kenneth; Tang, Qisheng 2002. Support of marine sustainability science. Science (New York, N.Y.), 297 5582, 772

Bleau, Brian L; Gostout, Christopher J; Sherman, Kenneth E; Shaw, Michael J; Harford, William V; Keate, Ray F; Bracy, Waldo P; Fleischer, David E 2002. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal endoscopy, 56 1, 1-6

Chung, Raymond T; Evans, Scott R; Yang, Yijun; Theodore, Dickens; Valdez, Hernan; Clark, Rebecca; Shikuma, Cecilia; Nevin, Thomas; Sherman, Kenneth E 2002. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS (London, England), 16 14, 1915-23

Goedert, James J; Eyster, M Elaine; Lederman, Michael M; Mandalaki, Titica; De Moerloose, Philippe; White, Gilbert C; Angiolillo, Anne L; Luban, Naomi L C; Sherman, Kenneth E; Manco-Johnson, Marilyn; Preiss, Liliana; Leissinger, Cindy; Kessler, Craig M; Cohen, Alan R; DiMichele, Donna; Hilgartner, Margaret W; Aledort, Louis M; Kroner, Barbara L; Rosenberg, Philip S; Hatzakis, Angelos 2002. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood, 100 5, 1584-9

Sherman, Kenneth E 2002. Diagnosis and management of the HCV/HIV-coinfected patient. AIDS clinical care, 14 5, 39-43, 48

Sherman, Kenneth E; Rouster, Susan D; Chung, Raymond T; Rajicic, Natasa 2002. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 6, 831-7

Sherman, Kenneth E; Rouster, Susan D; Horn, Paul S 2002. Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 35 4, 482-7

Sherman, K E; Rouster, S D; Feinberg, J 2001. Prevalence and genotypic variability of TTV in HIV-infected patients. Digestive diseases and sciences, 46 11, 2401-7

Zucker, S D; Qin, X; Rouster, S D; Yu, F; Green, R M; Keshavan, P; Feinberg, J; Sherman, K E 2001. Mechanism of indinavir-induced hyperbilirubinemia. Proceedings of the National Academy of Sciences of the United States of America, 98 22, 12671-6

Manocha, A P; Sossenheimer, M; Martin, S P; Sherman, K E; Venkatesan, T; Whitcomb, D C; Ulrich, C D 1999. Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). The American journal of gastroenterology, 94 3, 784-9

Mendenhall, C L; Finkelman, F; Means, R T; Sherman, K E; Nguyen, V T; Grossman, C E; Morris, S C; Rouster, S; Roselle, G A 1999. Cytokine response to BCG infection in alcohol-fed mice. Alcohol (Fayetteville, N.Y.), 19 1, 57-63

Sherman, K E; Rouster, S D; Mendenhall, C; Thee, D 1999. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology (Baltimore, Md.), 30 1, 265-70

Sherman, K E; Sickler, J; Aranda-Michel, J; Weber, F L; Martin, S; Whiting, J; Hanto, D 1999. Rimantadine for treatment of hepatitis C infection in liver transplant recipients. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 5 1, 25-8

Aranda-Michel, J; Sherman, K E 1998. Tests of the liver: use and misuse. The Gastroenterologist, 6 1, 34-43

Sherman, K E; Sjogren, M; Creager, R L; Damiano, M A; Freeman, S; Lewey, S; Davis, D; Root, S; Weber, F L; Ishak, K G; Goodman, Z D 1998. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology (Baltimore, Md.), 27 4, 1128-35

Sickler, J B; Simmons, R A; Cobb, D K; Sherman, K E 1998. Cutaneous necrosis associated with interferon alpha-2b. The American journal of gastroenterology, 93 3, 463-4

Sherman, K E; Mendenhall, C; Thee, D L; O'Brien, J; Rouster, S D 1997. Hepatitis C serotypes in nonalcoholic and alcoholic patients. Digestive diseases and sciences, 42 11, 2285-91

Jain, R; McLaren, B; Bejarano, P; Sherman, K E 1996. A 69-year-old man with cholestatic liver disease. Seminars in liver disease, 16 4, 445-9

Sherman, K E; Andreatta, C; O'Brien, J; Gutierrez, A; Harris, R 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology (Baltimore, Md.), 23 4, 688-94

Sherman, K E; Lewey, S M; Goodman, Z D 1995. Talc in the liver of patients with chronic hepatitis C infection. The American journal of gastroenterology, 90 12, 2164-6

Younossi Z.M.; Ratziu V.; Loomba R.; Rinella M.; Anstee Q.M.; Goodman Z.; Bedossa P.; Geier A.; Beckebaum S.; Newsome P.N.; Sheridan D.; Sheikh M.Y.; Trotter J.; Knapple W.; Lawitz E.; Abdelmalek M.F.; Kowdley K.V.; Montano-Loza A.J.; Boursier J.; Mathurin P.; Bugianesi E.; Mazzella G.; Olveira A.; Cortez-Pinto H.; Graupera I.; Orr D.; Gluud L.L.; Dufour J.F.; Shapiro D.; Campagna J.; Zaru L.; MacConell L.; Shringarpure R.; Harrison S.; Sanyal A.J.; Abdelmalek M.; Abrams G.; Aguilar H.; Ahmed A.; Aigner E.; Aithal G.; Ala A.; Alazawi W.; Albillos A.; Allison M.; Al-Shamma S.; Andrade R.; Andreone P.; Angelico M.; Ankoma-Sey V.; Anstee Q.; Anty R.; Araya V.; Arenas Ruiz J.I.; Arkkila P.; Arora M.; Asselah T.; Au J.; Ayonrinde O.; Bailey R.J.; Balakrishnan M.; Bambha K.; Bansal M.; Barritt S.; Bate J.; Beato J.; Behari J.; Bellot P.; Ben Ari Z.; Bennett M.; Berenguer M.; Beretta-Piccoli B.T.; Berg T.; Bonacini M.; Bonet L.; Borg B.; Bourliere M.; Bowman W.; Bradley D.; Brankovic M.; Braun M.; Bronowicki J.P.; Bruno S.; Cai C.; Calleja Panero J.L.; Carey E.; Carmiel M.; Carrión J.A.; Cave M.; Chagas C.; Chami T.; Chang A.; Coates A.; Cobbold J.; Corey K.; Corless L.; Crespo J.; Cruz Pereira O.; de Ledinghen V.; deLemos A. 12-14-2019. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multice The Lancet, 394 10215, 2184-2196

Bejarano P.; Koehler A.; Sherman K. 12-10-2001. Second opinion pathology in liver biopsy interpretation American Journal of Gastroenterology, 96 11, 3158-3164

Shire N.; Sherman K. 12-01-2006. Hepatitis B genotype C subgroups in Asia: Are they clinically relevant? Contagion: Reports, Cases, and Commentaries in HIV and Infectious Disease Research, 3 1, 15-17

Bodurka-Bevers D.; Dennis D.T.; Kaliner M.A.; Kopans D.B.; Sherman K.E. 12-01-2000. Five diagnostic controversies Patient Care, 34 3, 179-205

Soriano V.; Sherman K.; Rockstroh J.; Dieterich D.; Back D.; Sulkowski M.; Peters M. 11-28-2011. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected p AIDS, 25 18, 2197-2208

Goedert J.; Hatzakis A.; Sherman K.; Eyster M. 11-01-2001. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in p Journal of Infectious Diseases, 184 9, 1202-1205

Abu Dayyeh B.; Gupta N.; Sherman K.; de Bakker P.; Chung R. 10-07-2011. Il28b alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing pe PLoS ONE, 6 10,

Zucker S.; Benedict M.; Sherman K. 10-01-2006. Serum bilirubin and risk of colorectal cancer [1] Alimentary Pharmacology and Therapeutics, 24 8, 1257-1259

Sherman K.; Flamm S.; Afdhal N.; Nelson D.; Sulkowski M.; Everson G.; Fried M.; Adler M.; Reesink H.; Martin M.; Sankoh A.; Adda N.; Kauffman R.; George S.; Wright C.; Poordad F. 09-15-2011. Response-guided telaprevir combination treatment for hepatitis C virus infection New England Journal of Medicine, 365 11, 1014-1024

Masur H.; Kaplan J.E.; Holmes K.K.; Alston B.; Alter M.J.; Ampel N.; Anderson J.R.; Baker A.C.; Barr D.; Bartlett J.G.; Bennett J.E.; Benson C.A.; Bower W.A.; Bozzette S.A.; Brooks J.T.; Cargill V.A.; Castro K.G.; Chaisson R.E.; Cooper D.; Crumpacker C.S.; Currier J.S.; DeCock K.M.; Deyton L.; Dowell S.F.; Drew W.L.; Duncan W.R.; Dworkin M.S.; Dykewicz C.; Eisinger R.W.; Ellerbrock T.; El-Sadr W.; Feinberg J.; Freedberg K.A.; Fukuda K.; Furrer H.; Gatell J.M.; Gnann J.W.; Goldberger M.J.; Goldie S.; Goosby E.P.; Gordin F.; Gross P.A.; Hajjeh R.; Hafner R.; Havlir D.; Holmberg S.; Holtgrave D.R.; Hooton T.M.; Jabs D.A.; Jacobson M.A.; Jaffe H.; Janoff E.; Jones J.; Juranek D.D.; Kitahata M.; Kovacs J.A.; Leport C.; Levin M.J.; Lopez J.C.; Lundgren J.; Marco M.; Mast E.; Mayers D.; Mofenson L.M.; Montaner J.S.G.; Moore R.; Navin T.; Neaton J.; Nelson C.; O'Neill J.F.; Palefsky J.; Pau A.; Pellett P.; Phair J.P.; Piscitelli S.; Polis M.A.; Quinn T.C.; Reeves W.C.; Reiss P.; Rimland D.; Schuchat A.; Sears C.L.; Seeff L.; Sepkowitz K.A.; Sherman K.E.; Slama T.G.; Sloand E.M.; Spector S.A.; Stewart J.A.; Thomas D.L.; Uyeki T.M.; Van Dyke R.B.; Villarino M.E.; Wald A.; Watts D.H.; Wheat L.J.; Williams P.; Wright T.C. 09-03-2002. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 Annals of Internal Medicine, 137 5 II, 435-477

Chung R.T.; Davis G.L.; Jensen D.M.; Masur H.; Saag M.S.; Thomas D.L.; Aronsohn A.I.; Charlton M.R.; Feld J.J.; Fontana R.J.; Ghany M.G.; Godofsky E.W.; Graham C.S.; Kim A.Y.; Kiser J.J.; Kottilil S.; Marks K.M.; Martin P.; Mitruka K.; Morgan T.R.; Naggie S.; Raymond D.; Reau N.S.; Schooley R.T.; Sherman K.E.; Sulkowski M.S.; Vargas H.E.; Ward J.W.; Wyles D.L. 09-01-2015. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected Hepatology, 62 3, 932-954

Butt A.; Umbleja T.; Andersen J.; Sherman K.; Chung R. 09-01-2012. Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in he Clinical Infectious Diseases, 55 5, 631-638

Chak E.; Talal A.; Sherman K.; Schiff E.; Saab S. 09-01-2011. Hepatitis C virus infection in USA: An estimate of true prevalence Liver International, 31 8, 1090-1101

Goedert J.J.; Siegel J.; Miller K.; Lederman M.M.; Thompson A.; Browning B.; Gamerman S.; McRedmond K.; Withycombe J.; Gruppo R.; Stack G.; Lusher J.; Percy L.; Nugent D.; McDaniel M.; Manno C.; Butler R.; Wade A.; Angiolillo A.; Luban N.L.C.; Guelcher C.; Tarantino M.; Greer S.; Gill J.; Nelson J.; White G.; Fried M.; Grimsley A.L.; DiMichele D.; Goldberg I.; French J.; Hibner S.; Steinberg J.; Faust S.; Key N.; Hannemann V.; Kessler C.M.; Lee A.E.; Eyster M.E.; Galli K.; Jenkins G.; Bernstein Z.P.; Belling L.; Shapiro A.; Halley M.; Noblet P.; Jardine L.; Laudenbach L.; Lipton R.; Pece C.; Leissinger C.A.; Schmidt C.; Carr M.; Nolte M.; Manco-Johnson M.; Giambartolomei S.; Rubin S.H.; Belliveau D.; Aledort L.; McCarthy J.; Lemons R.; Bleak S.; Kraut E.; Witkoff L.; Sexauer C.; Kiplinger F.; Thompson A.; Cooper C.; Britton H.; Cobb K.; Reimers H.J.; Bagato J.A.; Powell J.S.; Herr M.; Scott K.; Hutter J.; Damiano M.L.; Navarro W.; Roth J.; Palascak J.; Sherman K.; Heffner M.; DiPaolo J.; Lammer M.; Iyer R.; Matthew P.; Schwartz M.; Konkle B.; Vijayanathan N.; Dugdale M.; Lilley D.; Hoots K.; Brown D.; Ullman M.; Neff A.; Klintworth S.; Sabio H.; Smith A.; Karafoulidou A. 09-01-2005. Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among Haemophilia, 11 5, 516-528

Theodore D.; Fried M.W.; Kleiner D.E.; Kroner B.L.; Goedert J.J.; Eyster M.E.; Faust S.P.; Sherman K.E.; Kessler C.M.; Francis C.; Aledort L.M. 09-01-2004. Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C Haemophilia, 10 5, 413-421

Eckman M.H.; Woodle E.S.; Thakar C.V.; Paterno F.; Sherman K.E. 08-21-2018. Kidney transplants for patients with hepatitis C virus infection Annals of Internal Medicine, 169 4, I16

Eckman M.H.; Woodle E.S.; Thakar C.V.; Paterno F.; Sherman K.E. 08-21-2018. Correction: Glycemic targets for older adults with type 2 diabetes (Annals of Internal Medicine (201 Annals of Internal Medicine, 169 12, 899

Murrison L.; Sherman K. 08-01-2017. The enigma of Hepatitis e Virus Gastroenterology and Hepatology, 13 8, 484-491

Kemmer N.; Sherman K. 07-24-2008. What is the impact of HIV infection on survival after liver transplantation? Commentary Nature Clinical Practice Gastroenterology and Hepatology, 5 8, 426-427

Sulkowski M.S.; Sherman K.E.; Dieterich D.T.; Bsharat M.; Mahnke L.; Rockstroh J.K.; Gharakhanian S.; Mccallister S.; Henshaw J.; Girard P.M.; Adiwijaya B.; Garg V.; Rubin R.A.; Adda M.; Soriano V. 07-16-2013. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients w Annals of Internal Medicine, 159 2, 86-96

Ragni M.; Sherman K.; Jordan J. 07-01-2010. Viral pathogens Haemophilia, 16 SUPPL. 5, 40-46

Khalsa J.; Kresina T.; Sherman K.; Vocci F. 07-01-2005. Medical management of HIV-hepatitis C virus coinfection in injection drug users Clinical Infectious Diseases, 41 1 SUPPL.,

Terrault N.; Roland M.; Schiano T.; Dove L.; Wong M.; Poordad F.; Ragni M.; Barin B.; Simon D.; Olthoff K.; Johnson L.; Stosor V.; Jayaweera D.; Fung J.; Sherman K.; Subramanian A.; Millis J.; Slakey D.; Berg C.; Carlson L.; Ferrell L.; Stablein D.; Odim J.; Fox L.; Stock P. 06-01-2012. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectio Liver Transplantation, 18 6, 716-726

Neff G.; Jayaweera D.; Sherman K. 06-01-2006. Drug-induced liver injury in HIV patients Gastroenterology and Hepatology, 2 6, 430-437

Root S.; DeAngelis S.; Sherman K. 06-01-1996. Preliminary evaluation of an automated device for percutaneous liver biopsy Journal of Clinical Gastroenterology, 22 4, 325-326

Eckman M.; Talal A.; Gordon S.; Schiff E.; Sherman K. 05-15-2013. Cost-effectiveness of screening for chronic hepatitis C infection in the United States Clinical Infectious Diseases, 56 10, 1382-1393

Eyster M.E.; Sherman K.E.; Goedert J.J.; Katsoulidou A.; Hatzakis A. 05-05-1999. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia Journal of Infectious Diseases, 179 5, 1062-1069

Hu K.Q.; Cui W.; Rouster S.D.; Sherman K.E. 05-01-2019. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfectio World Journal of Hepatology, 11 5, 442-449

Coffin C.; Stock P.; Dove L.; Berg C.; Nissen N.; Curry M.; Ragni M.; Regenstein F.; Sherman K.; Roland M.; Terrault N. 05-01-2010. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant reci American Journal of Transplantation, 10 5, 1268-1275

Shire N.; Sherman K. 05-01-2006. Vaccination against hepatitis A and B in patients with HIV Current Hepatitis Reports, 5 2, 63-67

Lempicki R.; Polis M.; Yang J.; McLaughlin M.; Koratich C.; Huang D.; Fullmer B.; Wu L.; Rehm C.; Masur H.; Lane H.; Sherman K.; Fauci A.; Kottilil S. 04-15-2006. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses b Journal of Infectious Diseases, 193 8, 1172-1177

Thomas D.; Bartlett J.; Peters M.; Sherman K.; Sulkowski M.; Pham P. 04-01-2012. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis Clinical Infectious Diseases, 54 7, 979-983

Sherman K. 04-01-2005. Special considerations in the management of HIV/HCV coinfection Advanced Studies in Medicine, 5 4 C,

Ryen R.; Friedman L.; Gress F.; Kaplan L.; Katz P.O.; Ouyang A.; Richter J.; Rosen H.; Sherman K.; Feldman M.; Lee S.P.; Banks P.F.; Richard Boland C.; Ahnen D.J.; Burt R.W.; Itzkowitz S.H.; Bass N.M.; Brown R.; Stevens P.; Klein S.; Aranda-Michel J.; Buchman A.; Floch M.; Heizer W.; Winter H.; Scharschmidt B.F.; Brenner D.A.; Hoofnagle J.H.; Hulley S.B.; Lieberman D.A.; Peura D.A.; Benya R.V.; McGuigan J.E.; Rao M.C.; Sternini C.; Valentine J.F.; Hall K.E.; Attar B.; Holt P.; Lee M.; Prather C.; Proctor D.D.; Anderson J.M.; Fisher R.M.L.; Wolf J.L. 04-01-2003. Training the gastroenterologist of the future: The gastroenterology core curriculum Gastroenterology, 124 4, 1055-1104

Poordad F.; McCone J.; Bacon B.R.; Bruno S.; Manns M.P.; Sulkowski M.S.; Jacobson I.M.; Reddy K.R.; Goodman Z.D.; Boparai N.; DiNubile M.J.; Sniukiene V.; Brass C.A.; Albrecht J.K.; Bronowicki J.P.; Colombato L.; Curciarello J.; Silva M.; Tanno H.; Terg R.; Adler M.; Langlet P.; Lasser L.; Nevens F.; Anderson F.; Bailey R.; Bilodeau M.; Cooper C.; Feinman S.V.; Heathcote J.; Levstik M.; Ramji A.; Sherman M.; Shafran S.; Yoshida E.; Achim A.; Ben Ali S.; Bigard M.A.; Bonny C.; Bourliere M.; Boyer-Darrigrand N.; Canva V.; Couzigou P.; De Ledinghen V.; Guyader D.; Hezode C.; Larrey D.; Latournerie M.; Marcellin P.; Mathurin P.; Maynard-Muet M.; Moussalli J.; Poupon R.; Poynard T.; Serfaty L.; Tran A.; Trepo C.; Truchi R.; Zarski J.P.; Berg T.; Dikopoulos N.; Eisenbach C.; Galle P.R.; Gerken G.; Goeser T.; Gregor M.; Klass D.; Kraus M.R.; Niederau C.; Schlaak J.F.; Schmid R.; Thies P.; Schmidt K.; Thimme R.; Weidenbach H.; Zeuzem S.; Angelico M.; Carosi G.; Craxì A.; Mangia A.; Pirisi M.; Rizzetto M.; Taliani G.; Zignego A.L.; Reesink H.W.; Serejo F.; Reymunde A.; Rosado B.; Torres E.; Barcena Marugan R.; De La Mata M.; Calleja J.L.; Castellano G.; Diago M.; Esteban R.; Fernandez-Rodriguez C.; Sanchez Tapias J.; Serra Desfilis M.A.; Afdhal N.; Al-Osaimi A. 03-31-2011. Boceprevir for untreated chronic HCV genotype 1 infection New England Journal of Medicine, 364 13, 1195-1206

Sherman K. 03-01-2006. Hepatitis C virus coinfection and other hepatic complications in HIV treatment Advanced Studies in Medicine, 6 3 B,

Seth A.; Sherman K.E. 02-01-2020. Hepatitis E: What We Think We Know Clinical Liver Disease, 15 S1, S37-S44

Zhang M.; O'Brien T.R.; Kopp W.C.; Goedert J.J.; Rosenberg P.S.; Rabkin C.S.; Engels E.A.; Whitby D.; Eyster M.E.; Konkle B.; Manco-Johnson M.; DiMichele D.; Hilgartner M.W.; Blatt P.; Aledort L.M.; Seremetes S.; Hoots K.; Angiolillo A.L.; Luban N.L.C.; Cohen A.; Manno C.S.; Leissinger C.; White G.C.; Lederman M.M.; Purvis S.; Salkowitz J.; Kessler C.M.; Karafoulidou A.; Mandalaki T.; Hatzakis A.; Touloumi G.; Schramm W.; Rommel F.; de Moerloose P.; Eichinger S.; Sherman K.E.; Kroner B.L. 01-18-2005. Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human imm BMC Blood Disorders, 5 ,

Gentene A.J.; Bell A.M.; Pence A.; Thomas K.; Jakubecz C.; Stacy E.; Woolf B.; Guido M.R.; Mueller E.W.; Sherman K.E. 01-01-2020. Sustained Virological Response of Patients Hospitalized Compared With Those Not Hospitalized During Annals of Pharmacotherapy, ,

Tamargo J.A.; Campa A.; Martinez S.S.; Li T.; Sherman K.E.; Zarini G.; Meade C.S.; Mandler R.N.; Baum M.K. 01-01-2020. Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies Journal of Psychoactive Drugs, ,

Sherman K.E.; Kang M.; Sterling R.; Umbleja T.; Marks K.; Kiser J.J.; Alston-Smith B.; Greaves W.; Butt A.A. 01-01-2017. Phase 3 trial of first generation protease inhibitor therapy for hepatitis c virus/human immunodefic World Journal of Hepatology, 9 4, 217-223

Anwar N.; Sherman K.E. 01-01-2014. HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure Clinical Liver Disease, 4 4, 80-83

Ragni M.; Devera M.; Roland M.; Wong M.; Stosor V.; Sherman K.; Hardy D.; Blumberg E.; Fung J.; Barin B.; Stablein D.; Stock P. 01-01-2013. Liver transplant outcomes in HIV(+) haemophilic men Haemophilia, 19 1, 134-140

Soriano V.; Barreiro P.; Sherman K.E. 01-01-2013. The changing epidemiology of liver disease in HIV patients AIDS Reviews, 15 1, 25-31

Sherman K.E. 01-01-2012. Preface HIV and Liver Disease, , v-vi

Sherman K.E. 01-01-2012. HIV and liver disease HIV and Liver Disease, , 1-209

Goedert J.J.; Brown D.L.; Hoots K.; Sherman K.E. 01-01-2004. Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments Haemophilia, Supplement, 10 4, 205-210

Goedert J.J.; Goedert J.J.; Hatzakis A.; Maloney E.M.; Eyster M.E.; O’Brien T.R.; Rosenberg P.S.; Rabkin C.S.; Engels E.A.; Hisada M.; Maloney E.; Gail M.H.; O’Brien S.J.; Dean M.; Carrington M.; Smith M.; Winkler C.; Eyster M.E.; Konkle B.; Manco-Johnson M.; Di Michele D.; Hilgartner M.W.; Blatt P.; Aledort L.M.; Seremetes S.; Hoots K.; Angiolillo A.L.; Luban N.L.C.; Cohen A.; Manno C.S.; Leissinger C.; White G.C.; Lederman M.M.; Purvis S.; Salkowitz J.; Kessler C.M.; Karafoulidou A.; Mandalaki T.; Hatzakis A.; Touloumi G.; Schramm W.; Rommel F.; de Moerloose P.; Eichinger S.; Sherman K.E.; Whitby D.; Waters D.; Lamprecht V.; Kroner B.L. 01-01-2000. Increased liver decompensation risk with atypical hepatitis C virus antibody levels Journal of Infectious Diseases, 182 2, 590-594

Bessesen M.; Ives D.; Condreay L.; Lawrence S.; Sherman K. 01-01-1999. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following Clinical Infectious Diseases, 28 5, 1032-1035

Sudduth R.; DeAngelis S.; Sherman K.; McNally P. 01-01-1995. The effectiveness of simethicone in improving visibility during colonoscopy when given with a sodium Gastrointestinal Endoscopy, 42 5, 413-415

Lawrence S.; Sherman K.; Lawson J.; Goodman Z. 01-01-1994. A 39 year old man with chronic hepatitis Seminars in Liver Disease, 14 1, 97-105

Sherman K.; Creager R.; O'Brien J.; Sargent S.; Piacentini S.; Thieme T. 01-01-1994. The use of oral fluid for hepatitis C antibody screening American Journal of Gastroenterology, 89 11, 2025-2027

Sherman K.E.; Narkewicz M.; Pinto P.C. 01-01-1994. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatiti Journal of Hepatology, 21 6, 1040-1047

Sherman K.E.; O'Brien J.; Gutierrez A.G.; Harrison S.; Urdea M.; Neuwald P.; Wilber J. 01-01-1993. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency Journal of Clinical Microbiology, 31 10, 2679-2682

Sherman K.; Goodman Z. 01-01-1992. End-stage liver disease in a 31-year-old man Seminars in Liver Disease, 12 3, 340-344

Sherman K.; Jones C. 01-01-1992. Hepatotoxicity associated with piroxicam use Gastroenterology, 103 1, 354-355

Sherman K.E.; Freeman S.; Harrison S.; Andron L. 01-01-1991. Prevalence of antibody to hepatitis c virus in patients infected with the human immunodeficiency vir Journal of Infectious Diseases, 163 2, 414-415

Sherman K.E.; Jones C.C.; Goldstein A.L.; Naylor P.H. 01-01-1991. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus Viral Immunology, 4 3, 195-199

Acquavita, Shauna P; Kauffman, Sandra S; Talks, Alexandra; Sherman, Kate . Pregnant women with substance use disorders: The intersection of history, ethics, and advocacy. Social work in health care, 55 10, 843-860

Lienesch, D W; Sherman, K E; Metzger, A; Shen, G Q . Anti-Clq antibodies in patients with chronic hepatitis C infection. Clinical and experimental rheumatology, 24 2, 183-5

Meyer, C A; White, C S; Sherman, K E . Diseases of the hepatopulmonary axis. Radiographics : a review publication of the Radiological Society of North America, Inc, 20 3, 687-98

Sherman, Kenneth E . Management of the Hepatitis B Virus/HIV-Coinfected Patient. Topics in antiviral medicine, 23 3, 111-4

Sherman, Kenneth E . Managing adverse effects and complications in completing treatment for hepatitis C virus infection. Topics in antiviral medicine, 20 4, 125-8

Sherman, Kenneth E . Advanced liver disease: what every hepatitis C virus treater should know. Topics in antiviral medicine, 19 3, 121-5